Knowledge-based planning for identifying high-risk stereotactic ablative radiotherapy treatment plans for lung tumors larger than 5cm

We retrospectively investigated the relationship between dosimetry and toxicity for Stereotactic ablative body radiotherapy (SABR) for lung tumors ≥5cm using a knowledge-based planning solution. This allowed to perform individualized treatment plan quality assurance and identified in nearly 50% of historical treatment plans from patients with grade≥3 toxicity where planning could have been improved.

https://ift.tt/2nDoMYU